These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1021 related articles for article (PubMed ID: 24464962)

  • 1. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
    Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
    Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center.
    Serrano R; Pons-Estel GJ; Espinosa G; Quintana RM; Reverter JC; Tassies D; Monteagudo J; Cervera R
    Lupus; 2020 Aug; 29(9):1050-1059. PubMed ID: 32536318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients.
    Cervera R; Khamashta MA; Shoenfeld Y; Camps MT; Jacobsen S; Kiss E; Zeher MM; Tincani A; Kontopoulou-Griva I; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Gromnica-Ihle E; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Roch B; Fernández-Nebro A; Piette JC; Espinosa G; Bucciarelli S; Pisoni CN; Bertolaccini ML; Boffa MC; Hughes GR;
    Ann Rheum Dis; 2009 Sep; 68(9):1428-32. PubMed ID: 18801761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
    Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
    Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
    Gómez-Puerta JA; Martín H; Amigo MC; Aguirre MA; Camps MT; Cuadrado MJ; Hughes GRV; Khamashta MA
    Medicine (Baltimore); 2005 Jul; 84(4):225-230. PubMed ID: 16010207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
    Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB
    J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome.
    Fujieda Y; Atsumi T; Amengual O; Odani T; Otomo K; Kato M; Oku K; Kon Y; Horita T; Yasuda S; Koike T
    Lupus; 2012 Dec; 21(14):1506-14. PubMed ID: 22936124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital based prospective longitudinal clinical and immunologic study of 179 patients of primary anti-phospholipid syndrome.
    Singh NK; Behera DR; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Singh U; Pandey LK; Matah M
    Int J Rheum Dis; 2013 Oct; 16(5):547-55. PubMed ID: 24164842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome.
    Krause I; Blank M; Fraser A; Lorber M; Stojanovich L; Rovensky J; Shoenfeld Y
    Immunobiology; 2005; 210(10):749-54. PubMed ID: 16325493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid syndrome and recurrent thrombosis in children.
    Berkun Y; Padeh S; Barash J; Uziel Y; Harel L; Mukamel M; Revel-Vilk S; Kenet G
    Arthritis Rheum; 2006 Dec; 55(6):850-5. PubMed ID: 17139660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E; Glidden DV; Elder ME
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal and pregnancy outcome in primary antiphospholipid syndrome: a 10-year experience in one medical center.
    Chou AK; Hsieh SC; Su YN; Jeng SF; Chen CY; Chou HC; Tsao PN; Hsieh WS
    Pediatr Neonatol; 2009 Aug; 50(4):143-6. PubMed ID: 19750887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomic distribution of venous thrombosis in patients with antiphospholipid antibody: imaging findings.
    Provenzale JM; Ortel TL
    AJR Am J Roentgenol; 1995 Aug; 165(2):365-8. PubMed ID: 7618558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity, mortality, and organ damage in patients with antiphospholipid syndrome.
    Grika EP; Ziakas PD; Zintzaras E; Moutsopoulos HM; Vlachoyiannopoulos PG
    J Rheumatol; 2012 Mar; 39(3):516-23. PubMed ID: 22247356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study.
    Fischer-Betz R; Specker C; Brinks R; Schneider M
    Lupus; 2012 Oct; 21(11):1183-9. PubMed ID: 22685017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.